GlassScriptPhysician profile
David C Lieber
NPI 1558462408
$4,929.24
in general payments reported to CMS, 2019-2025
24 companies · $457 in 2025
The $457 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $315 · 2021: $431 · 2022: $2,006 · 2023: $1,221 · 2024: $273 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,259 · Travel and Lodging: $593 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.56 |
| Travel and Lodging | $592.84 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $2,004.26 | 2022-2025 | Ecoin Device Kit |
| Boston Scientific Corporation | $795.08 | 2019-2025 | Lithovue, Ams 700, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $516.41 | 2019-2025 | Xtandi, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $281.55 | 2020-2023 | Lynparza |
| Merck Sharp & Dohme LLC | $239.05 | 2021-2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $204.07 | 2025 | Erleada, Rybrevant, Carvykti |
| Olympus America INC. | $158.15 | 2019-2023 | Itind System, Soltive |
| Abbvie INC. | $156.03 | 2020-2025 | |
| Janssen Scientific Affairs, LLC | $103.10 | 2022 | |
| Endo USA, INC. | $85.42 | 2024-2025 | Xiaflex, Aveed, Edex |
| Myriad Genetic Laboratories, INC. | $56.02 | 2021-2023 | Prolaris |
| Convatec INC. | $55.26 | 2022-2023 | |
| Progenics Pharmaceuticals, INC. | $49.16 | 2023-2024 | Pylarify |
| Ferring Pharmaceuticals INC. | $43.77 | 2024 | |
| Axonics, INC. | $39.10 | 2022-2023 | Bulkamid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $35.37 | 2025 | |
| Integra Lifesciences Corporation | $32.83 | 2022 | |
| Pfizer INC. | $30.85 | 2020-2023 | |
| Allergan, INC. | $23.34 | 2021 | |
| Endo Pharmaceuticals INC. | $20.42 | 2021 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.